| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $995K | — | -35.3% |
| R&D Expense | $5.9M | — | +47.1% |
| SG&A Expense | $10.7M | — | +2.1% |
| Operating Income | -$19.3M | — | -13.8% |
| Pre-tax Income | -$10.6M | — | +81.9% |
| Income Tax | $56K | — | -3.4% |
| Net Income | -$10.6M | — | +81.9% |
| EPS (Basic) | -$0.08 | — | +82.2% |
| EPS (Diluted) | -$0.12 | — | +73.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.6M | -31.6% | -79.7% |
| Short-term Investments | $112.4M | +4.6% | +195.8% |
| Accounts Receivable | $1.4M | -41.2% | -16.1% |
| Current Assets | $147.9M | -6.1% | -23.6% |
| Total Assets | $235.6M | -4.6% | -12.3% |
| Current Liabilities | $14.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.0M | — | +17.6% |
| Capital Expenditures | $10K | — | -66.7% |
| Investing Cash Flow | -$4.2M | — | -238.3% |
| Financing Cash Flow | $233K | — | -99.8% |
| Free Cash Flow | -$10.1M | — | +17.7% |
| +22.1% |
| Long-term Debt | $267.2M | -2.3% | +25.4% |
| Total Liabilities | $325.6M | -2.3% | +24.3% |
| Stockholders' Equity | -$90.0M | -4.3% | -1468.7% |